XML 25 R2.htm IDEA: XBRL DOCUMENT v3.22.2.2
INTERIM CONDENSED CONSOLIDATED STATEMENTS OF INCOME (LOSS) AND STATEMENTS OF COMPREHENSIVE INCOME (LOSS) - EUR (€)
€ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2022
Jun. 30, 2021
Jun. 30, 2022
Jun. 30, 2021
Statement Line Items [Line Items]        
Revenue € 23 € 0 € 42 € 0
Cost of sales (123) 0 (142) 0
Gross loss (100) 0 (100) 0
Cost of research and development (30,402) (10,432) (53,142) (12,825)
Selling and distribution expenses (524) (869) (1,012) (1,625)
General and administrative expenses (4,548) (3,767) (7,596) (7,673)
Other operating income/expenses 939 209 1,753 370
Impairment losses on financial assets 8 5 4 (2)
Operating loss (34,627) (14,854) (60,093) (21,755)
Interest and similar expense (526) (370) (923) (2,645)
Loss before tax (35,153) (15,224) (61,016) (24,400)
Taxes on income 0 0 0 0
Deferred taxes on expense 0 (41) 0 (41)
Loss for the period (35,153) (15,265) (61,016) (24,441)
Other comprehensive loss 0 32 0 (64)
Total comprehensive loss for the period € (35,153) € (15,234) € (61,016) € (24,505)
Loss per share in EUR        
Basic (in EUR per share) € (0.45) € (0.47) € (0.81) € (0.76)
Diluted (in EUR per share) € (0.45) € (0.47) € (0.81) € (0.76)
Weighted average number of shares for calculation of earnings per share        
Basic (in shares) 78,519,562 32,381,964 75,544,645 32,367,901
Diluted (in shares) 78,519,562 32,381,964 75,544,645 32,367,901